Abstract
BACKGROUND Ketamine may have antidepressant properties, but its acute psychoactive effects complicate successful masking in placebo-controlled trials.
METHODS In a triple-masked, randomized, placebo-controlled trial, 40 adult patients with major depressive disorder were randomized to a single infusion of ketamine (0.5 mg/kg) or placebo (saline) during anesthesia as usual for routine surgery. The primary outcome was depression severity measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) at 1, 2, and 3 days post-infusion. The secondary outcome was the proportion of participants with clinical response (≥50% reduction in MADRS scores) at 1, 2, and 3 days post-infusion. After all follow-up visits, participants were asked to guess which intervention they received.
RESULTS Mean MADRS scores did not differ between groups at screening or pre-infusion baseline. The mixed-effects model showed no evidence of effect of group assignment on post-infusion MADRS scores at 1 to 3 days post-infusion (−5.82, 95% CI −13.3 to 1.64, p=0.13). Clinical response rates were similar between groups (60% versus 50% on day 1) and comparable to previous studies of ketamine in depressed populations. Secondary and exploratory outcomes did not find statistical separation of ketamine from placebo. 36.8% of participants guessed their treatment assignment correctly; both groups allocated their guesses in similar proportions. One serious adverse event occurred in each group, unrelated to ketamine administration.
CONCLUSION In adults with major depressive disorder, a single dose of intravenous ketamine delivered during surgical anesthesia had no greater effect than placebo in acutely reducing the severity of depressive symptoms. This trial successfully masked treatment allocation in moderate-to-severely depressed patients using surgical anesthesia. While it is impractical to use surgical anesthesia for most placebo-controlled trials, future studies of novel antidepressants with acute psychoactive effects should make efforts to fully mask treatment assignment in order to minimize subject-expectancy bias. (ClinicalTrials.gov number, NCT03861988)
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03861988
Funding Statement
This study received faculty start-up funding from the Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine. BDH received support for this trial from the Society for Neuroscience in Anesthesia and Critical Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Stanford University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Several modifications were made to this manuscript. Firstly, the word "Randomized" was added to the Title. The Abstract was revised to avoid implying a generalizable lack of ketamine efficacy based on our data. The Introduction was updated to include a secondary aim to examine whether a conscious dissociative reaction to ketamine is necessary for an antidepressant response. In the Trial Oversight section, the trial sponsors and the rationale for not employing a data safety monitoring board were provided. The Trial Design and Procedures section now includes a brief overview of the N=5 open-label pilot study and an explanation for the absence of anesthetic standardization in the main RCT. Additionally, logistic regression was incorporated into the Statistical Methods section as an exploratory analysis. The Participants section now includes enrollment dates for the first and last participants, as well as the last day of follow-up. The Outcomes section now includes the results of the exploratory logistic regression. In the Protocol Violations and Safety section, a description of a second severe adverse event unrelated to participation in the research study was added. In the Discussion, additional text was included to address whether surgery and anesthesia alone have an antidepressant effect. The section also summarizes prior research showing that anesthetics possess antidepressant properties at doses that suppress EEG activity and highlights the distinctions between the current study and prior perioperative studies that recruited patients with depression. The Conclusion was revised to emphasize limitations arising from confounding surgical and anesthetic factors. An acknowledgment of support for author BDH from the Society of Neuroscience in Anesthesia and Critical Care was added. A copy error in Table 2, which concerned the number and percentage of participants receiving isoflurane for surgical anesthesia, was corrected. An additional figure, Extended Data Figure 1, was included, illustrating a reanalysis of MADRS data based on participants' guesses at the end of the study. Lastly, additional minor events were added to the protocol revision summary table.
Data Availability
De-identified participant data, data dictionaries, study protocol, and statistical analysis plan are available upon request after publication of the primary results manuscript in a peer-reviewed journal. To gain access to trial data for scientific research purposes, qualified researchers must submit a brief research proposal and statistical analysis plan for review and approval, and execute a data sharing agreement. Please direct all inquiries and requests to bheifets{at}stanford.edu.
